{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:26:38Z","timestamp":1792167998864,"version":"4.4.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T00:00:00Z","timestamp":1569974400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100009068","name":"Universit&amp;#x00E4;t Bern","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>An autoimmune response against myelin protein is considered one of the key pathogenic processes that initiates multiple sclerosis (MS). The currently available MS disease modifying therapies have demonstrated to reduce the frequency of inflammatory attacks. However, they appear limited in preventing disease progression and neurodegeneration. Hence, novel therapeutic approaches targeting both inflammation and neuroregeneration are urgently needed. A new pregnancy derived synthetic peptide, synthetic PreImplantation Factor (sPIF), crosses the blood-brain barrier and prevents neuro-inflammation. We report that sPIF reduces paralysis and de-myelination of the brain in a clinically-relevant experimental autoimmune encephalomyelitis mice model. These effects, at least in part, are due to post-translational modifications, which involve cyclic AMP dependent protein kinase (PKA), calcium-dependent protein kinase (PKC), and immune regulation. In terms of potential MS treatment, sPIF was successfully tested in neurodegenerative animal models of perinatal brain injury and experimental autoimmune encephalitis. Importantly, sPIF received a FDA Fast Track Approval for first in human trial in autommuninty (completed).<\/jats:p>","DOI":"10.1038\/s41598-019-48473-x","type":"journal-article","created":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T10:06:02Z","timestamp":1570010762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Synthetic PreImplantation Factor (sPIF) induces posttranslational protein modification and reverses paralysis in EAE mice"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2147-1982","authenticated-orcid":false,"given":"Soren","family":"Hayrabedyan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Shainer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanna","family":"Yekhtin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lola","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osnat","family":"Almogi-Hazan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuven","family":"Or","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles L.","family":"Farnsworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Newsome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krassimira","family":"Todorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Paidas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chaya","family":"Brodie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eytan R.","family":"Barnea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5594-0532","authenticated-orcid":false,"given":"Martin","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,2]]},"reference":[{"key":"48473_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.clim.2018.08.006","volume":"197","author":"X Zhang","year":"2018","unstructured":"Zhang, X. et al. IL-11 antagonist suppresses Th17 cell-mediated neuroinflammation and demyelination in a mouse model of relapsing-remitting multiple sclerosis. Clinical immunology 197, 45\u201353, https:\/\/doi.org\/10.1016\/j.clim.2018.08.006 (2018).","journal-title":"Clinical immunology"},{"issue":"3","key":"48473_CR2","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1515\/revneuro-2018-0017","volume":"30","author":"Berenice Anabel Silva","year":"2019","unstructured":"Silva, B. A. & Ferrari, C. C. Cortical and meningeal pathology in progressive multiple sclerosis: a new therapeutic target? Reviews in the neurosciences, https:\/\/doi.org\/10.1515\/revneuro-2018-0017 (2018).","journal-title":"Reviews in the Neurosciences"},{"key":"48473_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pharmthera.2017.12.004","volume":"185","author":"AR Wild","year":"2018","unstructured":"Wild, A. R. & Dell\u2019Acqua, M. L. Potential for therapeutic targeting of AKAP signaling complexes in nervous system disorders. Pharmacology & therapeutics 185, 99\u2013121, https:\/\/doi.org\/10.1016\/j.pharmthera.2017.12.004 (2018).","journal-title":"Pharmacology & therapeutics"},{"key":"48473_CR4","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.pharmthera.2004.10.012","volume":"105","author":"AG Leenders","year":"2005","unstructured":"Leenders, A. G. & Sheng, Z. H. Modulation of neurotransmitter release by the second messenger-activated protein kinases: implications for presynaptic plasticity. Pharmacology & therapeutics 105, 69\u201384, https:\/\/doi.org\/10.1016\/j.pharmthera.2004.10.012 (2005).","journal-title":"Pharmacology & therapeutics"},{"key":"48473_CR5","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1007\/s00239-003-2457-y","volume":"57","author":"R Selvatici","year":"2003","unstructured":"Selvatici, R. et al. Adaptative value of a PKC-PKI55 feedback loop of inhibition that prevents the kinase\u2019s deregulation. Journal of molecular evolution 57, 131\u2013139, https:\/\/doi.org\/10.1007\/s00239-003-2457-y (2003).","journal-title":"Journal of molecular evolution"},{"issue":"430","key":"48473_CR6","doi-asserted-by":"publisher","first-page":"eaao2304","DOI":"10.1126\/scitranslmed.aao2304","volume":"10","author":"Christina F. Vogelaar","year":"2018","unstructured":"Vogelaar, C. F. et al. Fast direct neuronal signaling via the IL-4 receptor as therapeutic target in neuroinflammation. Science translational medicine 10, https:\/\/doi.org\/10.1126\/scitranslmed.aao2304 (2018).","journal-title":"Science Translational Medicine"},{"key":"48473_CR7","doi-asserted-by":"publisher","first-page":"2078","DOI":"10.1038\/cdd.2015.55","volume":"22","author":"M Mueller","year":"2015","unstructured":"Mueller, M. et al. PreImplantation Factor bolsters neuroprotection via modulating Protein Kinase A and Protein Kinase C signaling. Cell death and differentiation 22, 2078\u20132086, https:\/\/doi.org\/10.1038\/cdd.2015.55 (2015).","journal-title":"Cell death and differentiation"},{"key":"48473_CR8","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1186\/1477-7827-9-63","volume":"9","author":"CW Stamatkin","year":"2011","unstructured":"Stamatkin, C. W. et al. PreImplantation Factor (PIF) correlates with early mammalian embryo development-bovine and murine models. Reproductive biology and endocrinology: RB&E 9, 63, https:\/\/doi.org\/10.1186\/1477-7827-9-63 (2011).","journal-title":"Reproductive biology and endocrinology: RB&E"},{"key":"48473_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1477-7827-11-105","volume":"11","author":"S Ramu","year":"2013","unstructured":"Ramu, S. et al. PreImplantation factor (PIF) detection in maternal circulation in early pregnancy correlates with live birth (bovine model). Reproductive biology and endocrinology: RB&E 11, 105, https:\/\/doi.org\/10.1186\/1477-7827-11-105 (2013).","journal-title":"Reproductive biology and endocrinology: RB&E"},{"issue":"402","key":"48473_CR10","doi-asserted-by":"publisher","first-page":"e401","DOI":"10.1016\/j.ajog.2010.06.060","volume":"203","author":"CM Duzyj","year":"2010","unstructured":"Duzyj, C. M. et al. Preimplantation factor promotes first trimester trophoblast invasion. American journal of obstetrics and gynecology 203(402), e401\u2013404, https:\/\/doi.org\/10.1016\/j.ajog.2010.06.060 (2010).","journal-title":"American journal of obstetrics and gynecology"},{"key":"48473_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.rbmo.2012.09.017","volume":"26","author":"RG Roussev","year":"2013","unstructured":"Roussev, R. G. et al. Preimplantation factor inhibits circulating natural killer cell cytotoxicity and reduces CD69 expression: implications for recurrent pregnancy loss therapy. Reproductive biomedicine online 26, 79\u201387, https:\/\/doi.org\/10.1016\/j.rbmo.2012.09.017 (2013).","journal-title":"Reproductive biomedicine online"},{"key":"48473_CR12","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jns.2011.07.050","volume":"312","author":"L Weiss","year":"2012","unstructured":"Weiss, L. et al. Preimplantation factor (PIF*) reverses neuroinflammation while promoting neural repair in EAE model. J Neurol Sci 312, 146\u2013157, https:\/\/doi.org\/10.1016\/j.jns.2011.07.050 (2012).","journal-title":"J Neurol Sci"},{"key":"48473_CR13","doi-asserted-by":"publisher","first-page":"21834","DOI":"10.18632\/oncotarget.15662","volume":"8","author":"G Migliara","year":"2017","unstructured":"Migliara, G. et al. PIF* promotes brain re-myelination locally while regulating systemic inflammation- clinically relevant multiple sclerosis M.smegmatis model. Oncotarget 8, 21834\u201321851, https:\/\/doi.org\/10.18632\/oncotarget.15662 (2017).","journal-title":"Oncotarget"},{"key":"48473_CR14","doi-asserted-by":"crossref","unstructured":"Hayrabedyan, S., Todorova, K., Spinelli, M., Barnea, E. R. & Mueller, M. The core sequence of PIF competes for insulin\/amyloid \u03b2 in insulin degrading enzyme \u2013 potential treatment for Alzheimer\u2019s disease. Oncotarget in press (2018).","DOI":"10.18632\/oncotarget.26057"},{"key":"48473_CR15","doi-asserted-by":"publisher","first-page":"13882","DOI":"10.1073\/pnas.1411674111","volume":"111","author":"M Mueller","year":"2014","unstructured":"Mueller, M. et al. PreImplantation factor promotes neuroprotection by targeting microRNA let-7. Proceedings of the National Academy of Sciences of the United States of America 111, 13882\u201313887, https:\/\/doi.org\/10.1073\/pnas.1411674111 (2014).","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"48473_CR16","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.pharmthera.2015.10.008","volume":"156","author":"ER Barnea","year":"2015","unstructured":"Barnea, E. R. et al. Immune regulatory and neuroprotective properties of preimplantation factor: From newborn to adult. Pharmacology & therapeutics 156, 10\u201325, https:\/\/doi.org\/10.1016\/j.pharmthera.2015.10.008 (2015).","journal-title":"Pharmacology & therapeutics"},{"key":"48473_CR17","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s12020-011-9438-5","volume":"40","author":"L Weiss","year":"2011","unstructured":"Weiss, L. et al. Preimplantation factor (PIF) analog prevents type I diabetes mellitus (TIDM) development by preserving pancreatic function in NOD mice. Endocrine 40, 41\u201354, https:\/\/doi.org\/10.1007\/s12020-011-9438-5 (2011).","journal-title":"Endocrine"},{"key":"48473_CR18","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1160\/TH15-08-0640","volume":"115","author":"YC Chen","year":"2016","unstructured":"Chen, Y. C. et al. PreImplantation factor prevents atherosclerosis via its immunomodulatory effects without affecting serum lipids. Thrombosis and haemostasis 115, 1010\u20131024, https:\/\/doi.org\/10.1160\/TH15-08-0640 (2016).","journal-title":"Thrombosis and haemostasis"},{"key":"48473_CR19","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.bbmt.2012.12.011","volume":"19","author":"Y Azar","year":"2013","unstructured":"Azar, Y. et al. Preimplantation factor reduces graft-versus-host disease by regulating immune response and lowering oxidative stress (murine model). Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation 19, 519\u2013528, https:\/\/doi.org\/10.1016\/j.bbmt.2012.12.011 (2013).","journal-title":"Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation"},{"key":"48473_CR20","doi-asserted-by":"publisher","first-page":"58975","DOI":"10.18632\/oncotarget.10635","volume":"7","author":"R Shainer","year":"2016","unstructured":"Shainer, R. et al. PreImplantation factor (PIF) therapy provides comprehensive protection against radiation induced pathologies. Oncotarget 7, 58975\u201358994, https:\/\/doi.org\/10.18632\/oncotarget.10635 (2016).","journal-title":"Oncotarget"},{"key":"48473_CR21","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1177\/1352458517729455","volume":"23","author":"H Lassmann","year":"2017","unstructured":"Lassmann, H. Targets of therapy in progressive MS. Multiple sclerosis 23, 1593\u20131599, https:\/\/doi.org\/10.1177\/1352458517729455 (2017).","journal-title":"Multiple sclerosis"},{"key":"48473_CR22","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/scd.2016.0108","volume":"26","author":"M Mueller","year":"2017","unstructured":"Mueller, M. et al. Wharton\u2019s Jelly Mesenchymal Stem Cells Protect the Immature Brain in Rats and Modulate Cell Fate. Stem cells and development 26, 239\u2013248, https:\/\/doi.org\/10.1089\/scd.2016.0108 (2017).","journal-title":"Stem cells and development"},{"key":"48473_CR23","doi-asserted-by":"publisher","first-page":"160","DOI":"10.3390\/proteomes3030160","volume":"3","author":"MP Stokes","year":"2015","unstructured":"Stokes, M. P. et al. Complementary PTM Profiling of Drug Response in Human Gastric Carcinoma by Immunoaffinity and IMAC Methods with Total Proteome Analysis. Proteomes 3, 160\u2013183, https:\/\/doi.org\/10.3390\/proteomes3030160 (2015).","journal-title":"Proteomes"},{"key":"48473_CR24","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1159\/000334499","volume":"9","author":"J Gawinecka","year":"2012","unstructured":"Gawinecka, J. et al. Desmoplakin as a potential candidate for cerebrospinal fluid marker to rule out 14-3-3 false positive rates in sporadic Creutzfeldt-Jakob disease differential diagnosis. Neurodegener. Dis. 9, 139\u2013144, https:\/\/doi.org\/10.1159\/000334499 (2012).","journal-title":"Neurodegener. Dis."},{"key":"48473_CR25","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1016\/j.cyto.2018.08.017","volume":"111","author":"S Pei","year":"2018","unstructured":"Pei, S. et al. Elevated soluble syndecan-1 levels in neuromyelitis optica are associated with disease severity. Cytokine 111, 140\u2013145, https:\/\/doi.org\/10.1016\/j.cyto.2018.08.017 (2018).","journal-title":"Cytokine"},{"key":"48473_CR26","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.pnpbp.2017.11.020","volume":"82","author":"GR Juszczak","year":"2018","unstructured":"Juszczak, G. R. & Stankiewicz, A. M. Glucocorticoids, genes and brain function. Progress in neuro-psychopharmacology & biological psychiatry 82, 136\u2013168, https:\/\/doi.org\/10.1016\/j.pnpbp.2017.11.020 (2018).","journal-title":"Progress in neuro-psychopharmacology & biological psychiatry"},{"key":"48473_CR27","doi-asserted-by":"publisher","first-page":"4551","DOI":"10.4049\/jimmunol.1300931","volume":"191","author":"X Zhang","year":"2013","unstructured":"Zhang, X., Wu, C., Song, J., Gotte, M. & Sorokin, L. Syndecan-1, a cell surface proteoglycan, negatively regulates initial leukocyte recruitment to the brain across the choroid plexus in murine experimental autoimmune encephalomyelitis. J. Immunol. 191, 4551\u20134561, https:\/\/doi.org\/10.4049\/jimmunol.1300931 (2013).","journal-title":"J. Immunol."},{"key":"48473_CR28","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00401-019-01980-7","volume":"137","author":"R Brambilla","year":"2019","unstructured":"Brambilla, R. The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis. Acta neuropathologica 137, 757\u2013783, https:\/\/doi.org\/10.1007\/s00401-019-01980-7 (2019).","journal-title":"Acta neuropathologica"},{"key":"48473_CR29","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1016\/j.neuint.2010.02.012","volume":"57","author":"J De Keyser","year":"2010","unstructured":"De Keyser, J. et al. Astrocytes as potential targets to suppress inflammatory demyelinating lesions in multiple sclerosis. Neurochemistry international 57, 446\u2013450, https:\/\/doi.org\/10.1016\/j.neuint.2010.02.012 (2010).","journal-title":"Neurochemistry international"},{"key":"48473_CR30","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1055\/s-0042-110791","volume":"49","author":"O Torres-Quesada","year":"2017","unstructured":"Torres-Quesada, O., Rock, R. & Stefan, E. Systematic Quantification of GPCR\/cAMP-Controlled Protein Kinase A Interactions. Hormone and metabolic research\u2009=\u2009Hormon- und Stoffwechselforschung\u2009=\u2009Hormones et metabolisme 49, 240\u2013249, https:\/\/doi.org\/10.1055\/s-0042-110791 (2017).","journal-title":"Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme"},{"key":"48473_CR31","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.pharmthera.2010.03.001","volume":"127","author":"MK Sun","year":"2010","unstructured":"Sun, M. K. & Alkon, D. L. Pharmacology of protein kinase C activators: cognition-enhancing and antidementic therapeutics. Pharmacology & therapeutics 127, 66\u201377, https:\/\/doi.org\/10.1016\/j.pharmthera.2010.03.001 (2010).","journal-title":"Pharmacology & therapeutics"},{"key":"48473_CR32","doi-asserted-by":"publisher","first-page":"171","DOI":"10.3389\/fncir.2013.00171","volume":"7","author":"WM Connelly","year":"2013","unstructured":"Connelly, W. M., Errington, A. C., Di Giovanni, G. & Crunelli, V. Metabotropic regulation of extrasynaptic GABAA receptors. Frontiers in neural circuits 7, 171, https:\/\/doi.org\/10.3389\/fncir.2013.00171 (2013).","journal-title":"Frontiers in neural circuits"},{"key":"48473_CR33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0301-0082(01)00002-8","volume":"65","author":"K Tanaka","year":"2001","unstructured":"Tanaka, K. Alteration of second messengers during acute cerebral ischemia - adenylate cyclase, cyclic AMP-dependent protein kinase, and cyclic AMP response element binding protein. Progress in neurobiology 65, 173\u2013207 (2001).","journal-title":"Progress in neurobiology"},{"key":"48473_CR34","doi-asserted-by":"publisher","first-page":"5437","DOI":"10.1523\/JNEUROSCI.3124-15.2016","volume":"36","author":"R Antonelli","year":"2016","unstructured":"Antonelli, R. et al. Pin1 Modulates the Synaptic Content of NMDA Receptors via Prolyl-Isomerization of PSD-95. J Neurosci 36, 5437\u20135447, https:\/\/doi.org\/10.1523\/JNEUROSCI.3124-15.2016 (2016).","journal-title":"J Neurosci"},{"key":"48473_CR35","doi-asserted-by":"publisher","first-page":"10141","DOI":"10.1523\/JNEUROSCI.5105-10.2011","volume":"31","author":"NZ Borgesius","year":"2011","unstructured":"Borgesius, N. Z. et al. betaCaMKII plays a nonenzymatic role in hippocampal synaptic plasticity and learning by targeting alphaCaMKII to synapses. J. Neurosci. 31, 10141\u201310148, https:\/\/doi.org\/10.1523\/JNEUROSCI.5105-10.2011 (2011).","journal-title":"J. Neurosci."},{"key":"48473_CR36","doi-asserted-by":"crossref","unstructured":"O\u2019Brien, C. et al. Randomized, Double-Blind, Placebo-Controlled, Single Ascending Dose Trial of Synthetic PreImplantation Factor in Autoimmune Hepatitis. Hepatology Communications In press (2018).","DOI":"10.1002\/hep4.1239"},{"key":"48473_CR37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s00401-016-1631-4","volume":"133","author":"H Lassmann","year":"2017","unstructured":"Lassmann, H. & Bradl, M. Multiple sclerosis: experimental models and reality. Acta neuropathologica 133, 223\u2013244, https:\/\/doi.org\/10.1007\/s00401-016-1631-4 (2017).","journal-title":"Acta neuropathologica"},{"key":"48473_CR38","doi-asserted-by":"publisher","first-page":"769","DOI":"10.2217\/imt.13.59","volume":"5","author":"ER Barnea","year":"2013","unstructured":"Barnea, E. R., Rambaldi, M., Paidas, M. J. & Mecacci, F. Reproduction and autoimmune disease: important translational implications from embryo-maternal interaction. Immunotherapy 5, 769\u2013780, https:\/\/doi.org\/10.2217\/imt.13.59 (2013).","journal-title":"Immunotherapy"},{"key":"48473_CR39","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.mayocp.2013.11.002","volume":"89","author":"DM Wingerchuk","year":"2014","unstructured":"Wingerchuk, D. M. & Carter, J. L. Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies. Mayo Clinic proceedings 89, 225\u2013240, https:\/\/doi.org\/10.1016\/j.mayocp.2013.11.002 (2014).","journal-title":"Mayo Clinic proceedings"},{"key":"48473_CR40","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1089\/scd.2016.0027","volume":"25","author":"B Oppliger","year":"2016","unstructured":"Oppliger, B. et al. Intranasal Delivery of Umbilical Cord-Derived Mesenchymal Stem Cells Preserves Myelination in Perinatal Brain Damage. Stem cells and development 25, 1234\u20131242, https:\/\/doi.org\/10.1089\/scd.2016.0027 (2016).","journal-title":"Stem cells and development"},{"key":"48473_CR41","first-page":"e155","volume":"7","author":"E Storey","year":"2002","unstructured":"Storey, E., Slavin, M. J. & Kinsella, G. J. Patterns of cognitive impairment in Alzheimer\u2019s disease: assessment and differential diagnosis. Front. Biosci. 7, e155\u2013184 (2002).","journal-title":"Front. Biosci."},{"key":"48473_CR42","doi-asserted-by":"publisher","first-page":"W276","DOI":"10.1093\/nar\/gkv459","volume":"43","author":"E Petsalaki","year":"2015","unstructured":"Petsalaki, E. et al. SELPHI: correlation-based identification of kinase-associated networks from global phospho-proteomics data sets. Nucleic Acids Res. 43, W276\u2013282, https:\/\/doi.org\/10.1093\/nar\/gkv459 (2015).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48473-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T13:19:14Z","timestamp":1671283154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-48473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,2]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["48473"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-48473-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,2]]},"assertion":[{"value":"30 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"sPIF is a proprietary (owned by BioIncept, LLC). E.R. Barnea, MD FACOG is CSO of BioIncept, LLC, NJ, USA. Authors declare no other conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12876"}}